Allergy & Rhinology (Jan 2022)

Chronic Spontaneous Urticaria Triggered by the AstraZeneca/Oxford COVID-19 Vaccine with Achieved Remission: A Case Report

  • Stephanie G Brooks MA,
  • Anna M De Jong,
  • Mina Abbaslou MD,
  • Gordon Sussman MD

DOI
https://doi.org/10.1177/21526567211068458
Journal volume & issue
Vol. 13

Abstract

Read online

New adverse reactions to the COVID-19 vaccines are being identified as vaccination rates increase worldwide. Recently, there have been two reports of Moderna (mRNA-1273) vaccine induced relapse of chronic spontaneous urticaria (CSU) that was previously well controlled. Herein, we report a case of AstraZeneca/Oxford (ChAdOx1) vaccine triggered CSU in a patient with no history of CSU with achieved remission.